Cost-effectiveness analysis of atorvastatin compared to simvastatin treatment in Greece
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2007, Vol 24, Issue 5
Abstract
OBJECTIVE To determine the cost-effectiveness of treatment with atorvastatin compared to simvastatin, generically priced, in achieving the NCEP ATP III LDL-cholesterol target levels in Greece. METHOD To compare atorvastatin and simvastatin, a "targeted" titration model was used to estimate goal attainment effectiveness, the annual drug and titration cost and cost efficiency, based on the proportion of patients achieving NCEP ATP III LDL treatment targets. The model considers a cohort of 1,000 patients for each statin, using the LDL-lowering efficacy, by dose, of atorvastatin 10-40 mg and simvastatin 20-40 mg, and the distributions of NHANES-3 survey data to compute the percentage of patients in each of the three NCEP ATP III coronary risk levels. The doses used in the model are those available in Greece. A cost component analysis was explored by taking into account (a) drug expenses, (b) laboratory costs, and (c) the cost of outpatient visits. Further, in order to obtain a wider view of the cost variation that occurs in Greece, differences between public and private health services were included in the model. RESULTS The percentage of patients receiving atorvastatin treatment and achieving the target levels of NCEP ATP III for LDL was 89.7% compared with 70% for patients receiving simvastatin. The total cost per patient achieving the target amounted, in the public sector, to € 689 for atorvastatin and € 808 for simvastatin, while the same cost in the private sector was € 1,726 and € 2,161, respectively. CONCLUSIONS The results from the comparison of atorvastatin 10-40 mg with generically priced simvastatin 20-40 mg demonstrate that atorvastatin is clinically superior and a more cost-effective choice for treating patients, using NCEP ATP III treatment goals, compared to simvastatin, according to the modelling scenario and cost conditions analysed.
Authors and Affiliations
J. YFANTOPOULOS, V. PAPAGIANNOPOULOU
Keywords
Related Articles
- EP ID EP159960
- DOI -
- Views 61
- Downloads 0
Osteomyelitis in children with acute lymphoblastic leukemia
The orchestrated procedures of hematopoiesis are characterized by the dynamic capability of the hematopoietic stem cells in all the phases of the cell cycle. Upregulation of the hematopoiesis procedures leads to high mal...
Acute myeloid leukemia and Cryptococcus CNS infection in a HIV-positive patient
A 43-year-old woman presenting with confusion, anemia, lymphopenia, thrombocytopenia and cervical microlymphadenopathy was admitted to the Hospital after complaining for 20 days of fever, headache and rachialgia. The pas...
Biofilms, man, environment
Microorganisms do not οnly exist as free-floating cells, but are commonly attached to either an inert or a living surface (sessile bacteria). They produce an extracellular polymere and, with other components create compl...
Hematologic dyscrasias caused by medication - Β. Dyscrasias of the white blood cell series
This is a review of the disturbances in the white blood cell series caused by therapeutic agents and chemicals. It is now well recognized that various medicines can affect the production, maturation, function and morphol...
Correlation of serum and urine antioxidants with age
OBJECTIVE Free radicals are produced in the human organism during normal metabolism, or as a result of the effect of certain food ingredients or pollutants. Free radicals can cause damage to lipids, proteins and DNA, by...